His medical history was significant for premature birth, hyperphagia from early childhood, morbid obesity (body mass index 40.63 kg/m 2 ), type 2 diabetes mellitus, hypertension, and social withdrawal
Abstract Background The global increase in type 2 diabetes mellitus (DM2) and obesity presents a significant public health challenge, as these interconnected conditions contribute to severe complications, including cardiovascular disease, stroke, and certain cancers
The market they are both chasing is huge, and largely untapped
The challenge is that appetite suppression from semaglutide has a neurobiological basis in your hypothalamus and brainstemregions your conscious mind cannot override indefinitely
Depending on the Courts ruling, the outcome could have an impact on the continued availability of semaglutide as well